Skip to main content

Annovera FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 28, 2021.

FDA Approved: Yes (First approved August 10, 2018)
Brand name: Annovera
Generic name: ethinyl estradiol and segesterone acetate
Dosage form: Vaginal System
Company: The Population Council
Treatment for: Birth Control

Annovera (ethinyl estradiol and segesterone acetate) is an estrogen and progestin vaginal contraceptive system indicated to prevent pregnancy for up to a year.

Development timeline for Annovera

Aug 10, 2018Approval FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.